NCB Busts Inter-State Drug Cartel In Pune; 5,970 Tablets Seized, Three Held

Pune : The Narcotics Control Bureau (NCB) team, Mumbai has busted an interstate drug syndicate in Pune and arrested three persons. Around 5,900 tablets of a drug were seized from their possession.
The drug, Nitrazepam, is used for the short term treatment of insomnia. The accused have linkages in other states, including Andhra Pradesh, Bihar and few other states. They were involved in procuring the drug from Bihar, which is only meant for the medicinal purpose, and selling it in Pune as a narcotic substance.

The arrested have been identified as Sagar B, Swaraj B and Rajesh BC, all residents of Pune. According to the NCB, Sagar was responsible for getting the drug from Bihar. Rajesh, who owns a medical store in Pune, was responsible for its procurement while Swaraj B was given the task of peddling it in the city.

The NCB team after receiving a tip-off about the parcel containing the drug laid a trap and nabbed the accused from a courier firm’s office in the city. “Based on specific information gathered during the analysis, a parcel was intercepted at a courier centre in Pune, meant to be delivered to Sagar.

On May 2, NCB-Mumbai officials, who had reached the courier office in Pune, set a trap, waited for Sagar to arrive to receive the consignment. Soon, Sagar and his friend Rajesh arrived in the courier office. After they took the parcel, they were intercepted.

After checking the parcel, it was found to be containing a total of 5,970 tablets of Nitrazepam,” NCB officials said in a press statement. “When questioned, Sagar confessed that the consignment was meant for Pune-based Swaraj B. On the night of May 2, Swaraj was also apprehended from Pune. Swaraj stated that he was involved in peddling the pharmaceutical drug,” the NCB officials added.
  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’